Literature DB >> 16932912

Association between the HER2 expression and histological differentiation in Wilms tumor.

M Salem1, Y Kinoshita, T Tajiri, R Souzaki, K Tatsuta, M Higashi, T Izaki, K Kohashi, M Tsuneyoshi, T Taguchi.   

Abstract

Human epidermal growth factor receptors (HER) play a critical role in the branching morphogenesis of renal tubules. In the current study, we analyzed the expression of HER2 in Wilms tumor and assessed the role of this gene in the tumorgenesis of Wilms tumor. During the period from 1960 to 2005, 40 patients with Wilms tumor were treated in our department. Twenty-four of those patients (except those with clear cell sarcoma of the kidney and malignant rhabdoid tumor of the kidney) were collected and assessed. The histological component of each Wilms tumor was divided into three categories (epithelial, blastemal, and mesenchymal) and the extent of HER2 protein expression was analyzed immunohistochemically. The normal kidney tissue accompanied with 12 cases of Wilms tumor was also examined. In the normal kidney, HER2 showed a strong immunoreactivity in the cell membranes of the collecting tubules and in the endothelial cells. Of 24 cases, 15 cases showed an epithelial component, while 24 cases had a blastemal component and 21 cases had a mesenchymal component, respectively. Among the 15 specimens with epithelial cell differentiation, eight (53.3%) showed HER2 immunoreactive epithelial cells. HER2 immunoreactive blastemal cells were present in 11 (45.8%) of 24 specimens with blastemal cells. On the other hand, only 3 (14.3%) of 21 specimens containing mesenchymal cells showed HER2 immunoreactivity. These results suggest that the extent of HER2 expression is associated with epithelial differentiation in Wilms tumor. These histological findings may therefore help to explain the development of Wilms tumor from the standpoint of histological differentiation.

Entities:  

Mesh:

Year:  2006        PMID: 16932912     DOI: 10.1007/s00383-006-1762-0

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  31 in total

Review 1.  Wilms' tumour: connecting tumorigenesis and organ development in the kidney.

Authors:  Miguel N Rivera; Daniel A Haber
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

2.  Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line.

Authors:  S Fukushige; K Matsubara; M Yoshida; M Sasaki; T Suzuki; K Semba; K Toyoshima; T Yamamoto
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

3.  Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha, and c-erb B-2 in nephroblastoma.

Authors:  M A Ghanem; T H Van Der Kwast; J C Den Hollander; M K Sudaryo; R B Mathoera; M M Van den Heuvel; M A Noordzij; R J Nijman; G J van Steenbrugge
Journal:  Cancer       Date:  2001-12-15       Impact factor: 6.860

4.  The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity.

Authors:  T Akiyama; C Sudo; H Ogawara; K Toyoshima; T Yamamoto
Journal:  Science       Date:  1986-06-27       Impact factor: 47.728

5.  Immunohistochemical localization of the epidermal growth factor, transforming growth factor alpha, and their receptor in the human mesonephros and metanephros.

Authors:  N Bernardini; F Bianchi; M Lupetti; A Dolfi
Journal:  Dev Dyn       Date:  1996-07       Impact factor: 3.780

6.  Cytoplasmic staining of erbB-2 but not mRNA levels correlates with differentiation in human thyroid neoplasia.

Authors:  S L Sugg; S Ezzat; L Zheng; I B Rosen; J L Freeman; S L Asa
Journal:  Clin Endocrinol (Oxf)       Date:  1998-11       Impact factor: 3.478

Review 7.  The biology of erbB-2/neu/HER-2 and its role in cancer.

Authors:  N E Hynes; D F Stern
Journal:  Biochim Biophys Acta       Date:  1994-12-30

8.  ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma.

Authors:  M Onda; S Matsuda; S Higaki; T Iijima; J Fukushima; A Yokokura; T Kojima; H Horiuchi; T Kurokawa; T Yamamoto
Journal:  Cancer       Date:  1996-01-01       Impact factor: 6.860

9.  Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival.

Authors:  L A Akslen; J E Varhaug
Journal:  Cancer       Date:  1995-11-01       Impact factor: 6.860

10.  Human epidermal growth factor receptor signaling contributes to tumor growth via angiogenesis in her2/neu-expressing experimental Wilms' tumor.

Authors:  Akiko Yokoi; Kimberly W McCrudden; Jianzhong Huang; Eugene S Kim; Samuel Z Soffer; Jason S Frischer; Anna Serur; Tamara New; Jenny Yuan; Mahesh Mansukhani; Kathleen O'toole; Darrell J Yamashiro; Jessica J Kandel
Journal:  J Pediatr Surg       Date:  2003-11       Impact factor: 2.545

View more
  5 in total

1.  HER2 testing in paired biopsy and excision specimens of gastric cancer: the reliability of the scoring system and the clinicopathological factors relevant to discordance.

Authors:  Shih-Chiang Huang; Kwai-Fong Ng; Shang-En Lee; Kuang-Hua Chen; Ta-Sen Yeh; Tse-Ching Chen
Journal:  Gastric Cancer       Date:  2014-12-17       Impact factor: 7.370

2.  HER2/neu expression: a predictor for differentiation and survival in children with Wilms tumor.

Authors:  Seham M Ragab; Rehab M Samaka; Tahany M Shams
Journal:  Pathol Oncol Res       Date:  2009-07-17       Impact factor: 3.201

3.  Her2/neu Expression in Wilms' Tumor and Correlation With Histopathologic Findings.

Authors:  Mashaallah Babashahi; Mitra Mehrazma; Seyed Javad Nasiri; Farid Azizi Jalilian; Mostafa Rezaei-Tavirani
Journal:  Iran J Cancer Prev       Date:  2013

4.  Expression of HER-2/neu in Oral Squamous Cell Carcinoma.

Authors:  Sana Mirza; Naila Hadi; Shahid Pervaiz; Sultan Zeb Khan; Sameer A Mokeem; Tariq Abduljabbar; Nawwaf Al-Hamoudi; Fahim Vohra
Journal:  Asian Pac J Cancer Prev       Date:  2020-05-01

5.  Evaluation of Tissue Expression and Salivary Levels of HER2/neu in Patients with Head and Neck Squamous cell Carcinoma.

Authors:  Soheil Pardis; Yasaman Sardari; Mohammad Javad Ashraf; Azadeh Andisheh Tadbir; Hooman Ebrahimi; Sara Purshahidi; Bijan Khademi; Mohammad Javad Fattahi; Marzieh Hamzavi
Journal:  Iran J Otorhinolaryngol       Date:  2012
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.